The Gross Margin of GlaxoSmithKline Pharmaceuticals Ltd (GLAXO.NS) is 62.90%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 62.90% |
| 2024-03-31 | 57.81% |
| 2023-03-31 | 57.12% |
| 2022-03-31 | 54.79% |
| 2021-03-31 | 53.24% |
| 2020-03-31 | 55.50% |
| 2019-03-31 | 52.66% |
| 2018-03-31 | 52.18% |
| 2017-03-31 | 46.42% |
| 2016-03-31 | 48.85% |